By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Ainos, Inc.

Ainos, Inc. (AIMD)

NASDAQ Currency in USD
$3.61
+$0.16
+4.64%
Last Update: 11 Sept 2025, 20:00
$16.79M
Market Cap
-1.79
P/E Ratio (TTM)
Forward Dividend Yield
$2.00 - $5.00
52 Week Range

AIMD Stock Price Chart

Explore Ainos, Inc. interactive price chart. Choose custom timeframes to analyze AIMD price movements and trends.

AIMD Company Profile

Discover essential business fundamentals and corporate details for Ainos, Inc. (AIMD) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Jan 2021

Employees

44.00

CEO

Chun-Hsien Tsai

Description

Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.

AIMD Financial Timeline

Browse a chronological timeline of Ainos, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 May 2026

Upcoming earnings on 5 Nov 2025

Earnings released on 13 Aug 2025

EPS came in at -$0.99 , while revenue for the quarter reached $4.66K .

Stock split effective on 30 Jun 2025

Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 12 May 2025

EPS came in at -$1.05 , while revenue for the quarter reached $106.21K .

Earnings released on 7 Mar 2025

EPS came in at -$1.30 .

Earnings released on 6 Nov 2024

EPS came in at -$1.65 .

Earnings released on 5 Aug 2024

EPS came in at -$2.45 .

Earnings released on 13 May 2024

EPS came in at -$2.85 , while revenue for the quarter reached $20.73K .

Earnings released on 8 Mar 2024

EPS came in at -$1.37 , while revenue for the quarter reached $19.90K .

Earnings released on 7 Feb 2024

EPS came in at -$0.73 , while revenue for the quarter reached $24.49K .

Stock split effective on 14 Dec 2023

Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 11 Aug 2023

EPS came in at -$3.00 , while revenue for the quarter reached $28.56K .

Earnings released on 12 May 2023

EPS came in at -$3.25 , while revenue for the quarter reached $49.16K .

Earnings released on 31 Mar 2023

EPS came in at -$2.75 , while revenue for the quarter reached $1.04M .

Earnings released on 7 Nov 2022

EPS came in at -$12.75 , while revenue for the quarter reached $1.76M .

Earnings released on 15 Aug 2022

EPS came in at -$0.25 , while revenue for the quarter reached $636.63K .

Stock split effective on 9 Aug 2022

Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 16 May 2022

EPS came in at -$3.75 , while revenue for the quarter reached $87.20K .

Earnings released on 21 Mar 2022

EPS came in at -$0.01 , while revenue for the quarter reached $26.40K .

Earnings released on 15 Nov 2021

EPS came in at -$37.48 , while revenue for the quarter reached $363.05K .

Earnings released on 20 Aug 2021

EPS came in at -$3.75 , while revenue for the quarter reached $202.99K .

Earnings released on 14 May 2021

EPS came in at -$0.19 , while revenue for the quarter reached $2.12K .

Earnings released on 30 Mar 2021

EPS came in at -$0.01 , while revenue for the quarter reached $687.00 .

Earnings released on 13 Nov 2020

EPS came in at -$0.12 , while revenue for the quarter reached $192.00 .

AIMD Stock Performance

Access detailed AIMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run